These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36382924)

  • 1. Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin.
    Shami JJP; Yan VKC; Wei Y; Alwafi H; Blais JE; Wan E; Wong CKH; Cheung KS; Leung WK; Wong MCS; Wong ICK; Chan EW
    J Intern Med; 2023 Mar; 293(3):371-383. PubMed ID: 36382924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
    Chen CH; Lin CL; Hsu CY; Kao CH
    QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin's role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Study.
    Lawler T; Walts ZL; Giurini L; Steinwandel M; Lipworth L; Murff HJ; Zheng W; Warren Andersen S
    Cancer Epidemiol; 2024 Jun; 90():102566. PubMed ID: 38518387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study.
    Shami JJP; Zhao J; Pathadka S; Wan EYF; Blais JE; Vora P; Soriano-Gabarró M; Cheung KS; Leung WK; Wong ICK; Chan EW
    BMJ Open; 2022 Feb; 12(2):e050510. PubMed ID: 35121597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus.
    Bradley MC; Ferrara A; Achacoso N; Ehrlich SF; Quesenberry CP; Habel LA
    Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):525-530. PubMed ID: 29716927
    [No Abstract]   [Full Text] [Related]  

  • 7. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
    Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
    BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
    Meng F; Song L; Wang W
    J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
    [No Abstract]   [Full Text] [Related]  

  • 9. Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models.
    Farmer RE; Ford D; Mathur R; Chaturvedi N; Kaplan R; Smeeth L; Bhaskaran K
    Int J Epidemiol; 2019 Apr; 48(2):527-537. PubMed ID: 30753459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
    He XK; Su TT; Si JM; Sun LM
    Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences.
    Wang Y; Xiao J; Zhao Y; Du S; Du J
    Int J Colorectal Dis; 2020 May; 35(5):827-835. PubMed ID: 32100113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
    Zanders MM; van Herk-Sukel MP; Vissers PA; Herings RM; Haak HR; van de Poll-Franse LV
    Br J Cancer; 2015 Jul; 113(3):403-10. PubMed ID: 26180924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
    Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
    Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.
    Sehdev A; Shih YC; Vekhter B; Bissonnette MB; Olopade OI; Polite BN
    Cancer; 2015 Apr; 121(7):1071-8. PubMed ID: 25424411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
    Tseng CH
    Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin usage and the risk of colorectal cancer: a national cohort study.
    Lee JW; Choi EA; Kim YS; Kim Y; You HS; Han YE; Kim HS; Bae YJ; Kim J; Kang HT
    Int J Colorectal Dis; 2021 Feb; 36(2):303-310. PubMed ID: 32968891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effects of metformin on colorectal adenoma incidence and malignant progression.
    Deng M; Lei S; Huang D; Wang H; Xia S; Xu E; Wu Y; Zhang H
    Pathol Res Pract; 2020 Feb; 216(2):152775. PubMed ID: 31818523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of metformin on colorectal carcinoma in type 2 diabetes mellitus patients: a Markov model analysis].
    Su T; Liao B; Dong Y; Peng Z; Zhou Q; Li B; Peng S; Zhang N
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):689-693. PubMed ID: 28643317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: national cohort study.
    Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Urbonas V; Smailyte G
    Eur J Cancer Prev; 2020 Jul; 29(4):289-293. PubMed ID: 31567536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.